Key CLL research from EHA 2011
14 Jul 2011
Key CLL research from EHA 2011
Dasatinib therapy for CML patients unsuitable for imatinib
VTD consolidation therapy for multiple myeloma
Patient non-compliance to treatment schedules
ASCO 2011 highlights
Multiple Myeloma: New Rescue Options For Patients After Front-Line Therapy
Philadelphia chromosome targeting; mantle cell lymphoma maintenance; double cord transplants; funding for haematology
Role of maintenance therapy in multiple myeloma
Auto transplants, 1st, 2nd & 3rd generation novel agents improve outlook in multiple myeloma
Second generation TKIs in chronic myeloid leukaemia
Reducing global cancer mortality
New findings in proteasome inhibitors for myeloma patients